Abstract
Sufficient assessment of potential candidates for orthotopic liver transplantation (OLT) is the most important factor for a low alcohol relapse rate after transplantation in patients suffering from alcoholic cirrhosis. In the current study the efficiency of pretransplant screening with carbohydrate-deficient transferrin (CDT) was analysed in patients on the waiting list for OLT. A prospective study was performed in 44 patients who had undergone OLT for alcoholic cirrhosis. All patients had had pretransplant assessment by a specialist psychologist and were found to have no problems with alcohol. Pre- and post-transplant CDT monitoring was performed. Overall, 790 CDT values were measured in the study population. The median observation period was 2.1 months before and 41.2 months after transplantation, respectively. In 35 patients (80%) pretransplant CDT values were found to be above the reference value, but only one patient suffered an alcohol relapse after transplantation. Of the nine patients (20%) who demonstrated normal CDT before transplantation, two suffered an alcohol relapse after transplantation. CDT is a very useful marker for the monitoring of an alcohol relapse in patients following OLT for alcoholic cirrhosis, as has been previously indicated. However, CDT does not appear to be useful as a pretransplant screening marker for selection of potential transplant candidates suffering from alcoholic cirrhosis.
Similar content being viewed by others
References
Beresford TP, Turcotte J, Merion R, Burtch G, Blow FC, Campell D, et al. A rational approach to liver transplantation for the alcoholic patient. Psychosomatics 1990; 31:241.
Everhart JE, Beresford TP. Liver transplantation for alcoholic liver disease: a survey of transplantation programs in the United States. Liver Transpl Surg 1997; 3:220.
Weinrieb RM, Van Horn DHA, McLellan AT, Lucey MR. Interpreting the significance of drinking by alcohol-dependent liver transplant patients: fostering candor is the key to recovery. Liver Transpl 2000; 6:769.
American Psychiatric Association: diagnostic and statistical manual of mental disorders, 3rd edn. American Psychiatric Association, Washington DC, 1980.
Ades J, Badawy A, Barrias JA, Besson J, Borg S, Chick J, et al. Guidelines on evaluation of treatment of alcohol dependence. Alcoholism 1994; 30:S5.
Stibler H, Hultcrantz R. Carbohydrate-deficient transferrin in serum in patients with liver disease. Alcohol Clin Exp Res 1987; 11:468.
European Liver Transplant Registry (http://www.eltr.com)
Neuberger J, Schulz KH, Day C, Fleig W, Berlakovich GA, Berenguer M, et al. Transplantation for alcoholic liver disease. J Hepatol 2002; 36:130.
Berlakovich GA, Steininger R, Herbst F, Barlan M, Mittlböck M, Mühlbacher F. Efficacy of liver transplantation for alcoholic cirrhosis with respect to recidivism and compliance. Transplantation 1994; 58:560.
Osorio RW, Ascher NL, Avery M, Bachetti P, Roberts JP, Lake JR. Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology 1994; 20:105.
Bird GL, O’Grady JG, Harvey FA, Calne RY, Williams R. Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse. BMJ 1990; 301:15.
Kumar S, Stauber RE, Gavaler JS, Basista MH, Dindzans VJ, Schade RR, et al. Orthotopic liver transplantation for alcoholic liver disease. Hepatology 1990; 11:159.
Gledhill J, Burroughs A, Rolles K, Davidson B, Blizard B, Lloyd G. Psychiatric and social outcomes following liver transplantation for alcoholic liver disease: a controlled study. J Psychosom Res 1999; 46:359.
Neuberger J, Tang H. Relapse after transplantation: European studies. Liver Transpl Surg 1997; 3:275.
Foster P, Fabrega F, Karademir S, Sankary HN, Mital D, Williams JW. Recidivation of abstinence from ethanol in alcoholic recipients following liver transplantation. Hepatology 1997; 25:1469.
Gerhardt TC, Goldstein RM, Urschel HC, Tripp LE, Levy MF, Husberg BS, et al. Alcohol use following liver transplantation for alcoholic cirrhosis. Transplantation 1996; 62:1060.
DiMartini A, Jain A, Irish W, Fitzgerald MG, Fung J. Outcome of liver transplantation in critically ill patients with alcoholic cirrhosis. Transplantation 1998; 66:298.
Bell H, Tallaksen C, Sjaheim T, Weberg R, Raknerud N, Orjasaeter H, et al. Serum carbohydrate deficient transferrin as a marker of alcohol consumption in patients with chronic liver disease. Alcohol Clin Exp Res 1993; 17:246.
Berlakovich GA, Windhager T, Freundorfer E, Lesch OM, Steininger R, Muehlbacher F. Carbohydrate deficient transferrin for detection of alcohol relapse after orthotopic liver transplantation for alcoholic cirrhosis. Transplantation 1999; 67: 1231.
Heinemann A, Sterneck M, Kuhlencordt R, Rogiers X, Schulz KH, Queen B, et al. Carbohydrate-deficient transferrin: diagnostic efficiency among patients with end-stage liver disease. Alcohol Clin Exp Res 1998; 22:1806.
Anton RF. Carbohydrate-deficient transferrin for detection and monitoring of sustained heavy drinking. What have we learned? Where do we go from here? Alcohol 2001; 25:185.
Anttila P, Järvi K, Latvala J, Blake JE, Niemelä O. Diagnostic characteristics of different carbohydrate-deficient transferrin methods in the detection of problem drinking: effects of liver disease and alcohol consumption. Alcohol Alcohol 2003; 38:415.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Berlakovich, G.A., Soliman, T., Freundorfer, E. et al. Pretransplant screening of sobriety with carbohydrate-deficient transferrin in patients suffering from alcoholic cirrhosis. Transpl Int 17, 617–621 (2004). https://doi.org/10.1007/s00147-004-0765-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00147-004-0765-9